1st Quarter - Report

DUTKO WORLDWIDE, LLC for EISAI INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
GARY ANDRES —
LAINE GLISSON —
ARTHUR SILVERMAN —
BRANDON SMITH —
CECIL SWAMIDOSS —
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (111th), H.R. 1260 (111th), S. 610 (111th), H.R. 1548 (111th), S. 515 (111th)

Defense DEF

Monitor federal legislation related to health care and defense issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
GARY ANDRES —
LAINE GLISSON —
ARTHUR SILVERMAN —
BRANDON SMITH —
CECIL SWAMIDOSS —
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (111th), H.R. 1548 (111th), S. 515 (111th), S. 610 (111th), H.R. 1260 (111th)

Copyright/Patent/Trademark CPT

Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
GARY ANDRES —
LAINE GLISSON —
ARTHUR SILVERMAN —
BRANDON SMITH —
CECIL SWAMIDOSS —
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 515 (111th), H.R. 1 (111th), S. 610 (111th), H.R. 1260 (111th), H.R. 1548 (111th)

Health Issues HCR

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
GARY ANDRES —
LAINE GLISSON —
ARTHUR SILVERMAN —
BRANDON SMITH —
CECIL SWAMIDOSS —
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 515 (111th), H.R. 1 (111th), S. 610 (111th), H.R. 1548 (111th), H.R. 1260 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.